Assessment of peripheral and tumor specific Tregs and Th17 cells in patients with endometrial cancer.
OBJECTIVE The frontline treatment for endometrial cancer (EC) is a hysterectomy; immunotherapy is approved, but has limited efficacy in all EC genotypes (mismatch repair genotypes). Understanding how EC pathogenesis affects the immune response is essential to determine effective interventions. Systemic inflammation, dr...